Later works showed that BCR-ABL1 oncoprotein, with constitutive tyrosine kinase activity, was generated from this balanced translocation which leads to leukemogenesis in CML (14, 15). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.